PBS Biotech is a leading manufacturer of single-use bioreactor systems and provider of process development services. PBS' bioreactors utilize proprietary Vertical-Wheel technology to create homogeneous and scalable mixing conditions for a variety of sensitive cell therapy products and cell culture applications. PBS Biotech's vision is to become the world's standard manufacturing platform for allogeneic cell-based therapies.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/09/23 | $22,000,000 |
Avego Management Broad Oak Capital Partners | undisclosed |
